• to reduced the chance of significant cardiovascular (coronary heart and blood vessel) issues in Grown ups with variety 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk printed a research on scientific journal Nature a few novel glucose-delicate insulin NNC2215 which will lessen the potential risk of hypoglycemia in animal models.[sixty se